Latest Press Releases
- Adaptive Phage Therapeutics Awarded Additional $8 Million from U.S. Department of Defense for Clinical Advancement of Phage to Address Unmet Needs in Infectious Diseases
- Adaptive Phage Therapeutics Appoints Michele Wales, Ph.D., J.D., as Chief Legal Officer
- Adaptive Phage Therapeutics Adds Jesse L. Goodman, M.D., M.P.H., to its Board of Directors
- Adaptive Phage Therapeutics Highlights the Publication of a Case Study of Investigational Phage Therapy for an Antibiotic-Resistant Bacterial Infection in a Child
- Adaptive Phage Therapeutics Announces Licensing Agreement with the Walter Reed Army Institute of Research
- Adaptive Phage Therapeutics to Present at the FDA and NIH Hosted Workshop on Science and Regulation of Bacteriophage Therapy
- Adaptive Phage Therapeutics Appoints Robert J. Hopkins, MD, MPH & TM, FACP, FIDSA, to Chief Medical Officer
- Adaptive Phage Therapeutics Expands Board Following Series B Financing led by Deerfield Management
- Adaptive Phage Therapeutics Announces Collaboration with Oyster Point Pharma to Target Ophthalmic Diseases
See all press releases